Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Osteosarcoma

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Osteosarcoma in 8 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Osteosarcoma is the most common primary bone tumor, but the pathogenesis is not well understood."1.34Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells. ( Choe, M; Choi, EM; Ha, KS; Han, JA; Kim, H; Kim, JI; Kim, SR; Kim, SS; Kim, YM; Lee, EJ; Park, JH, 2007)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbey, S1
Goossens, L1
Taverne, T1
Cornet, J1
Choesmel, V1
Rouaud, C1
Gimeno, G1
Yannic-Arnoult, S1
Michaux, C1
Charlier, C1
Houssin, R1
Hénichart, JP1
Matsuda, T1
Kondo, A1
Tsunashima, Y1
Togari, A1
Duan, DP1
Dang, XQ1
Wang, KZ1
Wang, YP1
Zhang, H1
You, WL1
Huang, FM1
Chou, MY1
Chang, YC1
Coetzee, M1
Haag, M1
Claassen, N1
Kruger, MC1
Lee, EJ1
Choi, EM1
Kim, SR1
Park, JH1
Kim, H1
Ha, KS1
Kim, YM1
Kim, SS1
Choe, M1
Kim, JI1
Han, JA1
Moalic, S1
Liagre, B2
Le Bail, JC1
Beneytout, JL2
Moalic-Juge, S1
Duval, R1
Corbiere, C1
Bianchi, A1
Bordji, K1
Bosgiraud, C1

Other Studies

8 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Osteosarcoma

ArticleYear
Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor.
    Bioorganic & medicinal chemistry letters, 2002, Mar-11, Volume: 12, Issue:5

    Topics: Animals; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors;

2002
Inhibitory effect of vitamin K(2) on interleukin-1beta-stimulated proliferation of human osteoblasts.
    Biological & pharmaceutical bulletin, 2010, Volume: 33, Issue:5

    Topics: Adult; Anticoagulants; Bone Neoplasms; Cell Line; Cell Proliferation; Cyclooxygenase 2; Cyclooxygena

2010
The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.
    Oncology reports, 2012, Volume: 28, Issue:5

    Topics: Animals; Apoptosis; Bone Neoplasms; Caspase 3; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Down

2012
Induction of cyclooxygenase-2 mRNA and protein expression by epoxy resin and zinc oxide-eugenol based root canal sealers in human osteoblastic cells.
    Biomaterials, 2003, Volume: 24, Issue:11

    Topics: Cells, Cultured; Cyclooxygenase 2; Epoxy Resins; Gene Expression Regulation, Enzymologic; Humans; Is

2003
Stimulation of prostaglandin E2 (PGE2) production by arachidonic acid, oestrogen and parathyroid hormone in MG-63 and MC3T3-E1 osteoblast-like cells.
    Prostaglandins, leukotrienes, and essential fatty acids, 2005, Volume: 73, Issue:6

    Topics: Animals; Arachidonic Acid; Cell Line; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase Inhibitors;

2005
Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells.
    Experimental & molecular medicine, 2007, Aug-31, Volume: 39, Issue:4

    Topics: Bone Neoplasms; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase 2; Cy

2007
Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
    International journal of oncology, 2001, Volume: 18, Issue:3

    Topics: Adenovirus E1A Proteins; Apoptosis; Arachidonic Acid; bcl-2-Associated X Protein; Blotting, Western;

2001
The anti-apoptotic property of NS-398 at high dose can be mediated in part through NF-kappaB activation, hsp70 induction and a decrease in caspase-3 activity in human osteosarcoma cells.
    International journal of oncology, 2002, Volume: 20, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Bone Neoplasms; Caspase 3; Caspases; Cyclin-Depe

2002